| Abstract |
Objective To study and analyze the nutritional status of patients with gynecological malignant tumors during the perioperative period, and to investigate the status of nutritional support, in order to provide some help for the follow-up work. Methods The time interval of this experiment was from February 2020 to March 2021, and 200 patients with gynecological malignant tumors were selected as the research objects. In this experiment, researchers should use the nutritional risk screening form to screen the selected patients with gynecological malignant tumors, record the nutritional status of the selected patients during the perioperative period, and investigate the types and methods of nutritional support for the selected patients , to record the occurrence of postoperative complications in patients. Results The number of perioperative nutritional risk and malnutrition in 200 gynecological malignant tumor patients selected in this experiment was 130 and 10, accounting for 65.00% and 5.00% of the total number of selected patients, respectively. A total of 117 of the 200 patients received nutritional support, accounting for 58.50%, and 117 patients received parenteral nutrition support, of which 10 received "all-in-one" infusion, accounting for 8.55%. The number of patients receiving "infusion" was 107, accounting for 91.45%; a total of 1 of the 200 selected patients received enteral nutrition support, accounting for 0.50%; among the 130 patients with nutritional risk, a total of 101 received Perioperative nutritional support accounted for 77.69%, and among the 70 patients without nutritional risk, 16 received nutritional support, accounting for 22.86%; a total of 130 patients had NRS 2002 score ≥ 3, of which postoperative The number of patients with complications was 22, accounting for 16.92%. There were 70 patients with NRS 2002 score < 3, and only 1 patient had postoperative complications, accounting for 1.43%. Conclusion Patients with gynecological malignant tumors have a high probability of nutritional risk in the perioperative period, and the nutritional support at this stage is not scientific and reasonable enough to meet the needs of patients, which is not conducive to the prognosis of patients. Actively improve.
|